Delivery Order SPE2DB22D1106-SPE2DB25FFAG7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,218.76 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays. This competitively awarded, firm fixed-price contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nayzilam 5 mg nasal sprays with a contract ceiling value of $1,987.32. This firm fixed-price delivery order, which is non-competitive and set-aside-free, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- This federal contract award is for the delivery of Nayzilam 5 mg nasal sprays to the Defense Logistics Agency (DLA). The $2,016.78 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. AmerisourceBergen is a subsidiary of the parent company Cencora, Inc., which does business as AmerisourceBergen. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,043.25 for Nayzilam 5 mg nasal sprays on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a delivery order valued at $1,043.25 to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. This delivery order is being fulfilled from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and...
- This is a $1,748.11 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Nayzilam 5 mg nasal sprays, a medication used to treat seizures. The order has a completion date of June 25, 2025 and is not set aside for any special business category. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a $1,008.39 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 5 mg Nayzilam nasal spray units. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 15 to August 16, 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,069.86 firm fixed price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4565906165 NAYZILAM 5 MG NASAL SPRAYS. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,314.12 firm-fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a medication used to treat seizures. The contract has an ultimate completion date of August 13, 2024 and is not set aside for any specific business categories. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,516,455 units of NAYZILAM 5 MG NASAL SPRAYS. The contract has a completion date of February 2, 2024 and a potential value of $1,344.52. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAG7Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $2,558.31 from the Defense Logistics Agency for the supply of Nayzilam 5 mg nasal spray. The contract was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, under firm fixed pricing with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The Defense Logistics Agency, operating under the Department of Defense, utilizes AmerisourceBergen as a prime pharmaceutical vendor to support military healthcare systems and other federal medical supply needs. This delivery order for Nayzilam, an emergency seizure medication administered via nasal spray, falls within the broader scope of the company's pharmaceutical distribution portfolio, which encompasses specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The contract is classified as a child delivery order under the parent IDC vehicle, enabling flexible fulfillment of critical medical commodities to support Defense Health Agency operations and other eligible government healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/29/25 |